UPTRAVI (Page 6 of 6)
PRINCIPAL DISPLAY PANEL — 200 mcg Tablet Bottle Carton
NDC 66215-602-06
Uptravi®
(selexipag)
tablets
200 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 400 mcg Tablet Bottle Carton
NDC 66215-604-06
Uptravi®
(selexipag)
tablets
400 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 600 mcg Tablet Bottle Carton
NDC 66215-606-06
Uptravi®
(selexipag)
tablets
600 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 800 mcg Tablet Bottle Carton
NDC 66215-608-06
Uptravi®
(selexipag)
tablets
800 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 1000 mcg Tablet Bottle Carton
NDC 66215-610-06
Uptravi®
(selexipag)
tablets
1000 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 1200 mcg Tablet Bottle Carton
NDC 66215-612-06
Uptravi®
(selexipag)
tablets
1200 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 1400 mcg Tablet Bottle Carton
NDC 66215-614-06
Uptravi®
(selexipag)
tablets
1400 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 1600 mcg Tablet Bottle Carton
NDC 66215-616-06
Uptravi®
(selexipag)
tablets
1600 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — Kit Carton
NDC 66215-628-20
TITRATION PACK
Uptravi®
(selexipag)
tablets
200 mcg
Rx only
140 film-coated
tablets
Uptravi®
(selexipag)
tablets
800 mcg
Rx only
60 film-coated tablets
janssen
PRINCIPAL DISPLAY PANEL — 1,800 mcg Vial Carton
NDC 66215-718-01
Uptravi®
(selexipag)
for injection
1,800 mcg/vial
FOR INTRAVENOUS INFUSION ONLY
Reconstitute and Dilute Prior to Use.
Single-dose vial. Discard unused portion.
Rx only
Sterile
One Vial
OPENHERE
UPTRAVI selexipag tablet, coated | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
UPTRAVI selexipag tablet, coated | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
UPTRAVI TITRATION PACK selexipag kit | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
UPTRAVI selexipag injection, powder, for solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Actelion Pharmaceuticals US, Inc. (002641228) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Excella GmbH | 329809800 | ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628), LABEL (66215-602), LABEL (66215-604), LABEL (66215-606), LABEL (66215-608), LABEL (66215-610), LABEL (66215-612), LABEL (66215-614), LABEL (66215-616), LABEL (66215-628), MANUFACTURE (66215-602), MANUFACTURE (66215-604), MANUFACTURE (66215-606), MANUFACTURE (66215-608), MANUFACTURE (66215-610), MANUFACTURE (66215-612), MANUFACTURE (66215-614), MANUFACTURE (66215-616), MANUFACTURE (66215-628), PACK (66215-602), PACK (66215-604), PACK (66215-606), PACK (66215-608), PACK (66215-610), PACK (66215-612), PACK (66215-614), PACK (66215-616), PACK (66215-628) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Almac Sciences Limited | 232665666 | API MANUFACTURE (66215-602), API MANUFACTURE (66215-604), API MANUFACTURE (66215-606), API MANUFACTURE (66215-608), API MANUFACTURE (66215-610), API MANUFACTURE (66215-612), API MANUFACTURE (66215-614), API MANUFACTURE (66215-616), API MANUFACTURE (66215-628), API MANUFACTURE (66215-718), ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628), ANALYSIS (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Butterworth Laboratories Ltd | 225081538 | ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Almac Pharma Services Limited | 233170864 | ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628), ANALYSIS (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
SGS Institut Fresenius GmbH | 317219699 | ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628) |
Establishment | |||
Name | Address | ID/FEI | Operations |
SGS Institut Fresenius GmbH | 341259550 | ANALYSIS (66215-602), ANALYSIS (66215-604), ANALYSIS (66215-606), ANALYSIS (66215-608), ANALYSIS (66215-610), ANALYSIS (66215-612), ANALYSIS (66215-614), ANALYSIS (66215-616), ANALYSIS (66215-628) |
Establishment | |||
Name | Address | ID/FEI | Operations |
AMATSIGROUP | 265402977 | MANUFACTURE (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Wickham Micro Limited | 228216353 | ANALYSIS (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Eurofins Amatsi Analytics | 270324185 | ANALYSIS (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Confarma France | 492738125 | ANALYSIS (66215-718) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Konapharma AG | 482314432 | MANUFACTURE (66215-718) |
Revised: 07/2022 Actelion Pharmaceuticals US, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.